AU2002306472C1 - Neurovirulent Virus (Cryptovirus) Within the Rubulavirus Genus and Uses Therefor - Google Patents

Neurovirulent Virus (Cryptovirus) Within the Rubulavirus Genus and Uses Therefor Download PDF

Info

Publication number
AU2002306472C1
AU2002306472C1 AU2002306472A AU2002306472A AU2002306472C1 AU 2002306472 C1 AU2002306472 C1 AU 2002306472C1 AU 2002306472 A AU2002306472 A AU 2002306472A AU 2002306472 A AU2002306472 A AU 2002306472A AU 2002306472 C1 AU2002306472 C1 AU 2002306472C1
Authority
AU
Australia
Prior art keywords
cryptovirus
seq
leu
antibody
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002306472A
Other languages
English (en)
Other versions
AU2002306472B2 (en
AU2002306472A1 (en
Inventor
Steven J. Robbins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRYPTIC AFFLICTIONS LLC
Original Assignee
CRYPTIC AFFLICTIONS LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRYPTIC AFFLICTIONS LLC filed Critical CRYPTIC AFFLICTIONS LLC
Publication of AU2002306472A1 publication Critical patent/AU2002306472A1/en
Application granted granted Critical
Publication of AU2002306472B2 publication Critical patent/AU2002306472B2/en
Priority to AU2008202524A priority Critical patent/AU2008202524A1/en
Publication of AU2002306472C1 publication Critical patent/AU2002306472C1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychiatry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
AU2002306472A 2001-02-07 2002-02-07 Neurovirulent Virus (Cryptovirus) Within the Rubulavirus Genus and Uses Therefor Ceased AU2002306472C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008202524A AU2008202524A1 (en) 2001-02-07 2008-06-06 Neurovirulent virus (cryptovirus) within the rebulavirus genus and uses therefor

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26725301P 2001-02-07 2001-02-07
US60/267,253 2001-02-07
PCT/US2002/004117 WO2002077211A2 (en) 2001-02-07 2002-02-07 A virus (cryptovirus) within the rubulavirus genus and uses therefor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2008202524A Division AU2008202524A1 (en) 2001-02-07 2008-06-06 Neurovirulent virus (cryptovirus) within the rebulavirus genus and uses therefor

Publications (3)

Publication Number Publication Date
AU2002306472A1 AU2002306472A1 (en) 2003-05-08
AU2002306472B2 AU2002306472B2 (en) 2008-03-06
AU2002306472C1 true AU2002306472C1 (en) 2008-10-30

Family

ID=23017976

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002306472A Ceased AU2002306472C1 (en) 2001-02-07 2002-02-07 Neurovirulent Virus (Cryptovirus) Within the Rubulavirus Genus and Uses Therefor
AU2008202524A Abandoned AU2008202524A1 (en) 2001-02-07 2008-06-06 Neurovirulent virus (cryptovirus) within the rebulavirus genus and uses therefor

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2008202524A Abandoned AU2008202524A1 (en) 2001-02-07 2008-06-06 Neurovirulent virus (cryptovirus) within the rebulavirus genus and uses therefor

Country Status (6)

Country Link
EP (1) EP1373477B1 (enExample)
JP (1) JP4324379B2 (enExample)
AT (1) ATE517179T1 (enExample)
AU (2) AU2002306472C1 (enExample)
CA (1) CA2436208C (enExample)
WO (1) WO2002077211A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
FR2938841B1 (fr) * 2008-11-21 2010-12-17 Centre Nat Rech Scient Proteines mutantes de la proteine f de piv-5 et de piv-2
FR2938840B1 (fr) * 2008-11-21 2010-12-17 Centre Nat Rech Scient Proteines mutantes de la proteine f de piv-5 et de piv-2
WO2011150320A2 (en) * 2010-05-27 2011-12-01 University Of Georgia Research Foundation, Inc. Activators of innate immunity
CN113481185B (zh) * 2021-08-05 2022-12-02 云南师范大学 一种耐盐β-半乳糖苷酶GalNC2-13及其制备方法和应用
WO2025076466A2 (en) * 2023-10-06 2025-04-10 Cyanvac Llc Piv5-based vaccines with modified antigen: methods of making and using the same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Bachmann et al., Arch. Virol., 1975, vol. 48, no. 2, pp. 107-120 *
Lin & Lamb, J. Virol., 2000, vol. 74, no. 19, pp. 9152-9166 *
NCBI database Accession No. AF052755, submitted 05 March 1998 *
Randall et al., J. Gen. Virol., 1987, vol. 68, no. 11, pp. 2769-2780 *

Also Published As

Publication number Publication date
WO2002077211A3 (en) 2003-10-16
EP1373477B1 (en) 2011-07-20
AU2002306472B2 (en) 2008-03-06
AU2008202524A1 (en) 2008-06-26
WO2002077211A8 (en) 2002-11-21
CA2436208A1 (en) 2002-10-03
ATE517179T1 (de) 2011-08-15
CA2436208C (en) 2014-04-15
JP2005503766A (ja) 2005-02-10
WO2002077211A2 (en) 2002-10-03
EP1373477A2 (en) 2004-01-02
JP4324379B2 (ja) 2009-09-02

Similar Documents

Publication Publication Date Title
Stephensen et al. Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC-and ALVAC-based CDV recombinants protect against symptomatic infection
Mahapatra et al. Matrix protein and glycoproteins F and H of Peste-des-petits-ruminants virus function better as a homologous complex
Fraser et al. Measles virus and its biology
Plotkin et al. Mumps vaccine
ES2344150T3 (es) Procedimientos y reactivos para diagnosticar la infeccion por hantavirus.
AU2008202524A1 (en) Neurovirulent virus (cryptovirus) within the rebulavirus genus and uses therefor
US20060053501A1 (en) Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses
Collen et al. Single amino acid differences are sufficient for CD4+ T-cell recognition of a heterologous virus by cattle persistently infected with bovine viral diarrhea virus
AU2002306472A1 (en) Neurovirulent Virus (Cryptovirus) Within the Rubulavirus Genus and Uses Therefor
Loughlin et al. The cell biology of acute childhood respiratory disease: therapeutic implications
US6899884B2 (en) Vaccine against mumps containing a jeryl-lynn virus strain
Loh Spumaviruses
AKASU Outbreak of Aseptic Meningitis due to ECHO-9 in Northern Kyushu Island inthe Summer of 1997
Breschkin et al. SSPE‐BIKEN: A Naturally arising hemagglutination‐defective mutant of measles virus
US20040162421A1 (en) Methods and compositions for screening of human Borna disease virus
Harter Sheep progressive pneumonia viruses
Plotkin et al. Mumps Section 2: 20 vaccine
Moss et al. Measles virus
Welter Development of a canine distemper virus model in ferrets for testing novel Morbillivirus vaccine strategies
MANOHARAN MOLECULAR CHARACTERIZATION OF PESTE DES, PETITS RUMINANTS VIRUS.
Vivo Recombinant Measles Viruses with
HK1012421B (en) Vaccine against mumps containing a jeryl-lynn virus strain
HK1070383A (en) Vaccine against mumps
HK1068898B (en) A virus causing respiratory tract illness in susceptible mammals
HK1068898A1 (en) A virus causing respiratory tract illness in susceptible mammals

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 21 MAY 2008.

FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 21 MAY 2008

MK14 Patent ceased section 143(a) (annual fees not paid) or expired
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 07 FEB 2013 TO 07 OCT 2013 IN WHICH TO PAY A RENEWAL FEE HASBEEN FILED .

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A RENEWAL FEE HAS BEEN EXTENDED TO 07 OCT 2013 .

MK14 Patent ceased section 143(a) (annual fees not paid) or expired